Technology area: Chemistry & Materials
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Manta Biosystems Inc. has 2 pending office actions in the Chemistry and Materials technology area. These 2 pending office actions are assigned to 2 distinct examiners. However, both of these examiners are located within 1 distinct art unit. The involvement of 1 distinct art unit suggests that the applications are being evaluated within the same technical group, even though 2 distinct examiners are providing feedback. This concentration in 1 distinct art unit can lead to consistent departmental policy application.
The busiest examiner for this portfolio is GORDON, BRIAN R, who is responsible for 1 busiest examiner pending office action. This 1 busiest examiner pending action is among the 2 pending office actions currently active for the company. With 2 distinct examiners, the applicant is receiving input from different sources. The 2 pending office actions in Chemistry and Materials represent the current prosecution workload. Managing 2 distinct examiners within 1 distinct art unit requires attention to the individual styles of the examiners while operating under the guidelines of that unit.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GORDON, BRIAN R | 1 | 65.3% | +19.0% |
| GZYBOWSKI, MICHAEL STANLEY | 1 | 67.6% | +52.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17614045 | LOW-VOLUME SYSTEMS FOR SAMPLE IDENTIFICATION | GZYBOWSKI, MICHAEL STANLEY | 112d overdue |
| 17910523 | SAMPLE CARTRIDGES | GORDON, BRIAN R | 35d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17614045 | LOW-VOLUME SYSTEMS FOR SAMPLE IDENTIFICATION | GZYBOWSKI, MICHAEL STANLEY | 112d overdue |
| 17910523 | SAMPLE CARTRIDGES | GORDON, BRIAN R | 35d overdue |
| Art Unit | Apps |
|---|---|
| 1798 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17910523 | SAMPLE CARTRIDGES | GORDON, BRIAN R | 1798 | §102§112 | Final Rejection | 35d overdue | Pending | Sep 09, 2022 |
| 17614045 | LOW-VOLUME SYSTEMS FOR SAMPLE IDENTIFICATION | GZYBOWSKI, MICHAEL STANLEY | 1798 | §102§103 | Non-Final OA | 112d overdue | Pending | Nov 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialManta Biosystems Inc. has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Brian R Gordon has the most, with 1 of Manta Biosystems Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
